We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0OB3 market cap is 479.94M. The company's latest EPS is EUR -0.7302 and P/E is -2.49.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 137.71M | 129.62M | 371.72M | 376.84M | 175.73M |
Operating Income | 855k | -55.24M | -61.35M | -113.4M | -82.07M |
Net Income | -1.74M | -64.39M | -73.43M | -143.28M | -101.43M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 264.72M | 449.16M | 817.35M | 621.34M | 460.06M |
Total Liabilities | 129.57M | 371.74M | 646.77M | 401.55M | 331.82M |
Total Equity | 135.15M | 77.42M | 170.58M | 219.8M | 128.25M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | 5.53M | 137.74M | 76.9M | -245.34M | -202.74M |
Investing | -10.69M | -19.34M | -93.12M | -29.05M | -20.58M |
Financing | -7.7M | 21.74M | 154.5M | 215.12M | 63.08M |
Market Cap | 479.94M |
Price to Earnings Ratio | -2.49 |
Price to Sales Ratio | 1.44 |
Price to Cash Ratio | 2.01 |
Price to Book Ratio | 1.97 |
Dividend Yield | - |
Shares Outstanding | 138.91M |
Average Volume (1 week) | 37.4k |
Average Volume (1 Month) | 36.08k |
52 Week Change | 0.00% |
52 Week High | 3.455 |
52 Week Low | 3.455 |
Spread (Intraday) | 0.17 (4.8%) |
Company Name | Valneva Se |
Address |
6 rue alain bombard saint-herblain, loire-atlantique 44800 |
Website | https://www.valneva.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions